These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Superiority of iodixanole vs hypoosmolar contrasts in the prevention of contrast-induced nephropathy in patients at risk: myth or reality?]. Recio-Mayoral A Med Clin (Barc); 2010 Sep; 135(8):362-4. PubMed ID: 20557906 [No Abstract] [Full Text] [Related]
5. Contrast agent-induced nephropathy: a simple way to identify patients with preexisting renal insufficiency. Ashley JB; Millward SF AJR Am J Roentgenol; 2003 Aug; 181(2):451-4. PubMed ID: 12876025 [No Abstract] [Full Text] [Related]
6. A simple pre-procedural risk score for contrast-induced nephropathy among patients with chronic total occlusion undergoing percutaneous coronary intervention. Liu Y; Liu YH; Chen JY; Tan N; Zhou YL; Li HL; Guo W; Duan CY; Chen PY Int J Cardiol; 2015 Feb; 180():69-71. PubMed ID: 25438216 [No Abstract] [Full Text] [Related]
7. Contrast-induced nephropathy: prevention and management of high-risk patients. Caixeta A; Nikolsky E; Mehran R Indian Heart J; 2008; 60(6):524-31. PubMed ID: 19276490 [No Abstract] [Full Text] [Related]
8. Risk stratification nomogram for nephropathy after abdominal contrast-enhanced computed tomography. Kim KS; Kim K; Hwang SS; Jo YH; Lee CC; Kim TY; Rhee JE; Suh GJ; Singer AJ; Kim HD Am J Emerg Med; 2011 May; 29(4):412-7. PubMed ID: 20825813 [TBL] [Abstract][Full Text] [Related]
9. Incidence and predictors of contrast-induced nephropathy following CT-angiography for clinically suspected acute pulmonary embolism. Kooiman J; Klok FA; Mos IC; van der Molen A; de Roos A; Sijpkens YW; Huisman MV J Thromb Haemost; 2010 Feb; 8(2):409-11. PubMed ID: 19943871 [No Abstract] [Full Text] [Related]
10. Risk factors for contrast-induced nephropathy. Toprak O; Cirit M Kidney Blood Press Res; 2006; 29(2):84-93. PubMed ID: 16707906 [TBL] [Abstract][Full Text] [Related]
11. [Contrast medica nephropathy. Better understanding of risk markers and follow up needed]. Sterner G; Hellström M; Lagerqvist B; Aspelin P; Nyman U Lakartidningen; 2009 Jun 24-Jul 7; 106(26-27):1737-42. PubMed ID: 19731735 [No Abstract] [Full Text] [Related]
12. Intravenous Contrast: Friend or Foe? A Review on Contrast-Induced Nephropathy. Do C Adv Chronic Kidney Dis; 2017 May; 24(3):147-149. PubMed ID: 28501076 [TBL] [Abstract][Full Text] [Related]
13. The incidence and predictors of contrast-induced nephropathy in adequately hydrated elderly patients with impaired renal function. Park KW; Koo BK; Kim HL; Kim YS; Jo SH; Lee HY; Kang HJ; Cho YS; Chung WY; Yeon TJ; Chae IH; Choi DJ; Kim HS; Oh BH; Park YB Nephrol Dial Transplant; 2007 Jun; 22(6):1794-5. PubMed ID: 17324945 [No Abstract] [Full Text] [Related]
14. Ultra-low contrast volumes reduce rates of contrast-induced nephropathy in patients with chronic kidney disease undergoing coronary angiography. Kane GC; Doyle BJ; Lerman A; Barsness GW; Best PJ; Rihal CS J Am Coll Cardiol; 2008 Jan; 51(1):89-90. PubMed ID: 18174044 [No Abstract] [Full Text] [Related]
15. The editor's roundtable: contrast agents and risk for contrast-induced nephropathy. Friedewald VE; Goldfarb S; Laskey WK; Vetrovec GW; Roberts WC Am J Cardiol; 2011 Jun; 107(12):1848-55. PubMed ID: 21640219 [No Abstract] [Full Text] [Related]